Estela Rodriguez: Douglas Figg on PKs- and finding the maximal effective dose in trials

Estela Rodriguez shared on X:

“Master talk by Doug Figg on PKs- and finding the maximal effective (not tolerated) dose in trials- navigating safety to innovation.”

Source: Estela Rodriguez/X

More posts featuring Estela Rodriguez on oncodaily.com

Estela (Estelamari)  Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials.